oregon psilocybin business

Oregon Psilocybin: Business Issues

We’ve been taking early calls on Oregon psilocybin for over a year, going back to when Measure 109 passed. I’m always happy to talk to people, but there simply isn’t much to do yet. Currently, the Oregon Psilocybin Advisory Board (“Board”) and its subcommittees are meeting to formulate recommendations on program rules. Eventually draft rules

oregon psilocybin licensing

Oregon Psilocybin: Licensing Subcommittee Update January 2022

Time for another Oregon psilocybin licensing discussion update. We have now crossed the halfway point of the Oregon Health Authority (OHA) two-year development phase to create regulations based on Ballot Measure 109. As a reminder, there are five subcommittees covering different aspects of the emerging psilocybin industry. They include: research, health equity, manufacturing, training, and

Washington Psilocybin Bill Would Legalize Supported Adult Use

Washington Psilocybin Bill Would Legalize Supported Adult Use

This article was first published yesterday on Harvard Law School’s Petrie-Flom Center Bill of Health Blog. On Tuesday, Washington State legislators filed SB 5660, a bill that would legalize the supported adult use of psilocybin by people 21 years of age and older. Washington Psilocybin Services Wellness and Opportunity Act Sponsored by Senators Jesse Salomon and Liz Lovelett,

oregon psilocybinoregon psilocybin

The Evolution of Oregon Psilocybin Laws

Oregon’s Measure 109 allows for the manufacture, delivery, and administration of psilocybin, the compound found in “magic mushrooms.” But how was psilocybin made illegal in the first place? Originally, psilocybin was illegal under Oregon Revised Statute (ORS) 475.005. This law is Oregon’s “mini” controlled substances act. As in all other states, the Oregon law is

oregon psilocybin licensing

Oregon Psilocybin: Licensing Subcommittee Update December 2021

Time for an Oregon psilocybin licensing discussion update. Ballot Measure 109 gave the Oregon Health Authority (“OHA”) two years to create regulations for the manufacturing, testing, sale, and supervised administration of psilocybin. This two-year development phase started on January 1, 2021, and on March 18 Governor Kate Brown appointed members to the Oregon Psilocybin Advisory

Announcing New Blog: Psychedelics Law Blog

Announcing the Psychedelics Law Blog!

Harris Sliwoski is pleased to announce the Psychedelics Law Blog! The Psychedelics Law Blog is a forum for discussing and analyzing the impact of psychedelics laws and reform on industry stakeholders, including health care operators, entrepreneurs, investors, regulators, advocates and others. On this new blog, we will continue to cover the psychedelics law and policy issues

new york psilocybin legalization legislation

New York Introduces Medical Psilocybin Legislation

On Monday, November 13, 2021, New York Assemblyman Pat Burke introduced medical psilocybin legislation. The “purpose or general idea of bill” provides a good summary: this legislation would “create psilocybin service centers to provide innovative treatment options for ailments such as PTSD, depression, alcohol dependency, anxiety, among others.” The bill echoes two separate pieces of

psychedelic retreat legal liability

Psychedelic Retreats: Organizer Legal Issues

Psychedelic retreats are all the rage (and that’s not a new thing), which causes a variety of organizer legal issues and a corresponding spectrum of liabilities. At Wonderland Miami, Horizons NYC, and on a regular basis outside of conferences, we are asked about legal advice for the organizers of psychedelic retreats. Both recreational and therapeutic


DMT Therapy: Coming to a Clinic Near You?

DMT, or N, N-dimethyltryptamine is a powerful psychedelic. DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back